Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 11/2015

01-11-2015 | Letter to the Editor

Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study

Authors: Sara Bigliardi, Monica Morselli, Leonardo Potenza, Giovanni Riva, Valeria Coluccio, Monica Maccaferri, Ambra Paolini, Elisabetta Colaci, Valeria Fantuzzi, Francesco Soci, Vincenzo Nasillo, Andrea Messerotti, Laura Arletti, Valeria Pioli, Elisabetta Lugli, Andrea Gilioli, Chiara Quadrelli, Daniela Vallerini, Patrizia Barozzi, Ivana Lagreca, Roberto Marasca, Franco Narni, Erica Franceschini, Mauro Codeluppi, Cristina Mussini, Mario Luppi, Fabio Forghieri

Published in: Annals of Hematology | Issue 11/2015

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Hirsch HH, Martino R, Ward KN, Boeckh M, Einsele H, Ljungman P (2013) Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus. Clin Infect Dis 56:258–266PubMedCentralCrossRefPubMed
2.
Shah DP, Ghantoji SS, Mulanovich VE, Ariza-Heredia EJ, Chemaly RF (2012) Management of respiratory viral infections in hematopoietic cell transplant recipients. Am J Blood Res 2:203–218PubMedCentralPubMed
3.
Shah JN, Chemaly RF (2011) Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. Blood 117:2755–2763CrossRefPubMed
4.
Chemaly RF, Ghosh S, Bodey GP, Rohatgi N, Safdar A, Keating MJ, Champlin RE, Aguilera EA, Tarrand JJ, Raad II (2006) Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients. A retrospective study at a major cancer center. Medicine 85:278–287CrossRefPubMed
5.
Khanna N, Widmer AF, Decker M, Steffen I, Halter J, Heim D, Weisser M, Gratwohl A, Fluckiger U, Hirsch HH (2008) Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. Clin Infect Dis 46:402–412CrossRefPubMed
6.
Whimbey E, Englund JA, Couch RB (1997) Community respiratory virus infections in immunocompromised patients with cancer. Am J Med 102:10–18, discussion 25–6CrossRefPubMed
7.
Marcolini JA, Malik S, Suki D, Whimbey E, Bodey GP (2003) Respiratory disease due to parainfluenza virus in adult leukemia patients. Eur J Clin Microbiol Infect Dis 22:79–84PubMed
8.
Torres HA, Aguilera EA, Mattiuzzi GN, Cabanillas ME, Rohatgi N, Sepulveda CA, Kantarjian HM, Jiang Y, Safdar A, Raad II, Chemaly RF (2007) Characteristics and outcome of respiratory syncytial virus infection in patients with leukemia. Haematologica 92:1216–1223CrossRefPubMed
9.
Chemaly RF, Hanmod SS, Rathod DB, Ghantoji SS, Jiang Y, Doshi A, Vigil K, Adachi JA, Khoury AM, Tarrand J, Hosing C, Champlin R (2012) The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation. Blood 119:2738–2745CrossRefPubMed
Metadata
Title
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study
Authors
Sara Bigliardi
Monica Morselli
Leonardo Potenza
Giovanni Riva
Valeria Coluccio
Monica Maccaferri
Ambra Paolini
Elisabetta Colaci
Valeria Fantuzzi
Francesco Soci
Vincenzo Nasillo
Andrea Messerotti
Laura Arletti
Valeria Pioli
Elisabetta Lugli
Andrea Gilioli
Chiara Quadrelli
Daniela Vallerini
Patrizia Barozzi
Ivana Lagreca
Roberto Marasca
Franco Narni
Erica Franceschini
Mauro Codeluppi
Cristina Mussini
Mario Luppi
Fabio Forghieri
Publication date
01-11-2015
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 11/2015
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-015-2455-3

Other articles of this Issue 11/2015

Annals of Hematology 11/2015 Go to the issue

Original Article

Danazol therapy for the anemia of myelofibrosis: assessment of efficacy with current criteria of response and long-term results

Original Article

Pretransplantation use of the second-generation tyrosine kinase inhibitors has no negative impact on the HCT outcome

Original Article

Anemia among Muslim Bedouin and Jewish women of childbearing age in Southern Israel

Original Article

The influence of rituximab, high-dose therapy followed by autologous stem cell transplantation, and age in patients with primary CNS lymphoma

Letter to the Editor

Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome

Original Article

Cytotoxic effects of high concentrations of sodium ascorbate on human myeloid cell lines
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits